PRCT
Procept Biorobotics Corp
17.50$
-1.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | +76.4% | +52.9% | +123.3% | +17.9% | +2.3% | +17.0% | +40.0% | +17.6% | +21.9% | +16.8% | +2.6% | +35.6% | +6.0% | +24.2% | +2.2% | +19.8% | +9.4% | +16.9% | +1.4% | +14.5% | +5.2% | -8.3% | +8.8% | +13.7% | – | |
| – | +0.0% | +4.8% | +28.7% | +33.2% | +33.5% | -9.5% | +27.0% | +15.7% | +26.1% | +23.3% | +29.5% | -9.1% | +23.2% | +10.6% | +37.6% | -12.6% | +12.1% | -1.9% | +14.5% | +1.8% | +16.1% | +6.6% | -2.8% | -2.9% | +10.1% | – | |
| – | – | – | – | +650.4% | +1.6% | +18.3% | +6.5% | +70.3% | +10.3% | +20.6% | +4.3% | +17.0% | +47.5% | +2.4% | +12.6% | +17.8% | +25.8% | +17.2% | +18.3% | +1.1% | +13.6% | +4.4% | -11.6% | +16.5% | +15.6% | – | |
| – | +0.0% | -0.7% | +16.7% | -0.5% | -1.0% | +9.9% | +3.2% | -1.3% | +33.8% | +13.1% | +27.7% | +10.9% | +8.2% | -0.1% | +25.0% | -9.7% | +33.8% | -4.9% | -9.5% | +8.9% | -2.2% | +3.3% | +15.0% | +12.6% | -6.4% | – | |
| – | – | – | +29.5% | +13.3% | +18.8% | -1.5% | +34.3% | +13.0% | +6.9% | +25.9% | +5.2% | +15.7% | +7.7% | +1.4% | +10.4% | +9.0% | +3.1% | +4.6% | +13.2% | +14.2% | +2.0% | +4.8% | -1.2% | +11.6% | +7.0% | – | |
| – | +0.0% | -0.1% | +24.9% | +8.7% | +12.8% | +1.6% | +25.3% | +9.6% | +12.7% | +22.7% | +10.5% | +14.4% | +7.8% | +1.0% | +14.2% | +3.7% | +10.7% | +1.8% | +6.8% | +13.0% | +1.0% | +4.5% | +2.3% | +11.9% | +3.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +27.7% | -17.3% | -1.9% | +2.3% | -2.0% | -1.3% | +1.4% | +1.0% | -40.5% | +2.3% | +8.9% | +5.6% | +10.4% | -7.1% | -1.4% | +10.7% | -15.0% | -9.5% | +2.1% | +2.7% | -2.7% | -8.5% | +2.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +24.9% | -17.1% | +1.1% | -44.7% | -1,164.6% | – | -11.6% | -61.2% | +516.5% | -124.9% | – | -189.1% | – | -37.8% | – | – | – | – | – | – | – | -122.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.